Global Nanopore Sequencing Market is poised to witness a healthy growth of 26% by 2026 - Growing Occurrence of Infectious Diseases : Key Players are Oxford, Stratos Genomics, BaseClear, CD Genomics

Nanopore Sequencing, a fourth-generation sequencing technology, in which single strands of DNA or RNA are passed through tiny protein channel called as nanopore. These nanopores are embedded in an electrically resistant membrane which causes changes in the ion current, determining the sequence and modifications of bases.

Several Advantages of Nanopore Sequencing Technology fuels Its Market Demand

Over the years, there has been a significant rise in the adoption of nanopore sequencing for research as well as for clinical applications because of multiple benefits of nanopores such as label-free & ultralong reads and high throughput. Some of the manjor benefits which are driving its global market demand are as follows:
• Long-read Sequencing: The ability to produce ultra-long reads of over 2 Mb is a key advantage of nanopore sequencing. Longer read lengths are more likely to cover full regions of repeated sequence and structural variation, allowing for a more comprehensive understanding of genetic variants and the reconstruction of complex genomes.
• Targeted Sequencing: For nanopore sequencing, a variety of targeted sequencing approaches, such as targeted panels and whole exome enrichment, are available, leveraging both PCR- and hybrid capture-based targeted enrichment strategies.
• Rapid Results: Unlike traditional sequencing approaches, which need analysis after sequencing is completed, nanopore sequencing allows for early insights to be gained as soon as the sequencing process begins.
• Low Cost of Sequencer: High-end sequencers from Illumina and PacBio are priced over $950k and $450k respectively which are too expensive as compared to the GridION nanopore-based sequencer offered by Oxford Nanopore Technologies at $49k.
• Growing Clinical Applications: Nanopore sequencing is widely used for pathogen analysis such as outbreak surveillance of infectious diseases such as tuberculosis, Ebola, Zika, dengue fever, and Covid19, among others. Nanopore sequencing is also widely used by researchers and clinicians for cancer genomics and genetic disease diagnosis.

Partnerships, Collaborations and Acquisitions to boost adoption and co-develop Advanced Market solutions

The nanopore sequencing market has witnessed a number of partnerships, collaborations and acquisition by leading market players to either enhance the adoption of this technology for clinical applications or to co-develop advanced sequencing platforms. Some of the strategic initiatives that boosted the adoption of nanopore sequencing are listed as below:
• In April 2022, Oxford Nanopore Technologies collaborated with Genomics England to evaluate the benefits of sequencing for enhancing patient care and advancing research activities for the development of novel treatments on a larger scale using nanopore sequencing technology.
• In September 2021, Oxford Nanopore Technologies collaborated with Oracle to explore novel applications of genomic sequencing using the Oracle Cloud Infrastructure (OCI) to speed-up discovery of medical innovations.

Competitive Landscape Analysis: Nanopore Sequencing Market

The global nanopore sequencing market is marked by the presence of established market players such as Oxford Nanopore Technologies (UK), Stratos Genomics, a Roche company (US), BaseClear B.V. (Netherlands), CD Genomics (US), and others.

Get Detailed Insights on Nanopore Sequencing Market with a FREE Sample Report @ https://meditechinsights.com/nanopore-sequencing-market/

Ruta Halde
Associate, Medi-Tech Insights
+32 498 86 80 79
info@meditechinsights.com
https://meditechinsights.com/

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have successfully completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services.

This release was published on openPR.